Humana’s stock was headed for another sharp selloff on Tuesday, toward a more than four-year low, after the government cut its rating on one of the health insurer’s large Medicare Advantage plans because it missed some performance measures.
Humana’s stock was headed for another sharp selloff on Tuesday, toward a more than four-year low, after the government cut its rating on one of the health insurer’s large Medicare Advantage plans because it missed some performance measures.